Sucrose oral powder
Requires a prescription from a doctor or prescriber
A nonreducing disaccharide composed of glucose and fructose linked via their anomeric carbons.
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Yellow Card
Report side effects (MHRA)
Drug safety updates
MHRA alerts for Sucrose
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Suspected adverse reactions reported for Sucrose
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
View EudraVigilance report
Suspected adverse reactions reported for Sucrose
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Guidelines from the National Institute for Health and Care Excellence
NICE clinical guidance(5)
Chronic heart failure in adults: diagnosis and management (NG106)
Chronic kidney disease: assessment and management (NG203)
End of life care for infants, children and young people with life-limiting conditions: planning and management (NG61)
Dementia, disability and frailty in later life – mid-life approaches to delay or prevent onset (NG16)
Type 2 diabetes in adults: management (NG28)
Source: National Institute for Health and Care Excellence (NICE). Contains public sector information licensed under the Open Government Licence v3.0.
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 25 · Randomised trials: 7 · 1981–2026
Showing the 50 most relevant studies, sorted by most relevant.
M. Edmonds, J. Lázaro-Martínez, Jesús Alfayate-García, et al.
The lancet. Diabetes & endocrinology, 2017
R. Slater, L. Cornelissen, L. Fabrizi, et al.
Lancet, 2010
O. Stein, D. Granot
Frontiers in Plant Science, 2019
Jinmi Yoon, Lae-Hyeon Cho, Win Tun, et al.
Plant science : an international journal of experimental plant biology, 2021
H. Wan, Limin Wu, Yuejian Yang, et al.
Trends in plant science, 2017
Katharina Schmölzer, Alexander Gutmann, Margo Diricks, et al.
Biotechnology advances, 2016
Camacho-Pernil M, Tirado-Hernández P, Rodríguez-García M, et al.
2026
K. Koch
Current opinion in plant biology, 2004
Yong-ling Ruan
Annual review of plant biology, 2014
O. Aluko, Chuanzong Li, Qian Wang, et al.
International Journal of Molecular Sciences, 2021
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Pharmacology and chemical data from DrugBank
Key facts
Drug status
Approved
Major interactions
None known
Half-life
Not available
Mechanism
Not available
Food interactions
None known
Human targets
5 targets
Data: DrugBank · CC BY-NC 4.0
Pharmacokinetics at a glance
Proteins and enzymes this drug interacts with in the body
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Show
Chemical identifiers
CAS, UNII, InChI Key and database cross-references
Linked compound data from DrugBank Open Data (CC BY-NC 4.0)
Sucrose
Additional database identifiers
Drugs Product Database (DPD)
8818
ChemSpider
5768
BindingDB
50108105
ZINC
ZINC000004217475
GenBank Gene Database
X04121
GenBank Protein Database
581568
UniProt Accession
BLAC_STAAU
HUGO Gene Nomenclature Committee (HGNC)
HGNC:14905
GenAtlas
TAS1R2
GeneCards
TAS1R2
GenBank Gene Database
AF458154
GenBank Protein Database
20142333
UniProt Accession
TS1R2_HUMAN
GenBank Gene Database
J01611
GenBank Protein Database
145267
UniProt Accession
AMPC_ECOLI
HUGO Gene Nomenclature Committee (HGNC)
HGNC:6740
GeneCards
LYZ
UniProt Accession
LYSC_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:129
GenAtlas
ACTA1
GeneCards
ACTA1
GenBank Gene Database
J00068
GenBank Protein Database
178029
UniProt Accession
ACTS_HUMAN
GenBank Gene Database
AJ011781
UniProt Accession
AMYS_NEIPO
GenBank Gene Database
AF252621
UniProt Accession
Q9L5C8_ECOLX
UniProt Accession
Q939N4_ECOLX
UniProt Accession
Q9L5C7_ECOLX
UniProt Accession
Q840M4_ECOLX
GenBank Gene Database
U73860
UniProt Accession
HMUO_CORDI
HUGO Gene Nomenclature Committee (HGNC)
HGNC:798
GenAtlas
ATOX1
GeneCards
ATOX1
GenBank Gene Database
U70660
UniProt Accession
ATOX1_HUMAN
HUGO Gene Nomenclature Committee (HGNC)
HGNC:26935
GeneCards
RTCB
UniProt Accession
RTCB_HUMAN
UniProt Accession
OCP_LIMMA
GenBank Gene Database
X57400
UniProt Accession
SCRY_SALTM
GenBank Gene Database
Z94043
UniProt Accession
LSC_BACSU
DrugBank citations
If you use DrugBank data in your research, please cite:
- DrugBank 6.02024Recommended citationKnox C., Wilson M., Klinger C.M., et alDrugBank 6.0: the DrugBank Knowledgebase for 2024Nucleic Acids Res. 2024 Jan 552(D1):D1265-D1275
- DrugBank 5.02018Wishart D.S., Feunang Y.D., Guo A.C., et alDrugBank 5.0: a major update to the DrugBank database for 2018Nucleic Acids Res. 2017 Nov 846(D1):D1074-D1082
- DrugBank 4.02014Law V., Knox C., Djoumbou Y., et alDrugBank 4.0: shedding new light on drug metabolismNucleic Acids Res. 2014 Jan 142(1):D1091-7
- DrugBank 3.02011Knox C., Law V., Jewison T., et alDrugBank 3.0: a comprehensive resource for 'omics' research on drugsNucleic Acids Res. 2011 Jan39(Database issue):D1035-41
- DrugBank 2.02008Wishart D.S., Knox C., Guo A.C., et alDrugBank: a knowledgebase for drugs, drug actions and drug targets.Nucleic Acids Research2008 Jan36(Database issue):D901-6
- DrugBank 1.02006Wishart D.S., Knox C., Guo A.C., et alDrugBank: a comprehensive resource for in silico drug discovery and exploration.Nucleic Acids Research2006 Jan 134(Database issue):D668-72